RxDoctor Payments Data

Kelly Flynn

Family · Walterboro, SCNPI 1104425990

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,409 and has fallen 94.8% since, to $73 in 2025.

$2,170in general payments, 2019–2025

Across 127 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$258
  • GSK$204
  • AbbVie$194
  • Novartis$192
  • AstraZeneca$179
  • Merck$142
  • plus $1000 from 17 others

What the payments were for

  • Food & beverage$2,170100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,170 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina →

Other family in Walterboro

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →